Claire THALAMAS
Claire THALAMAS
PH, CIC 1436 (CHU Toulouse, Inserm, UT3),TMBI (Univ. Toulouse)
Verified email at inserm.fr - Homepage
Title
Cited by
Cited by
Year
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial
F Chollet, J Tardy, JF Albucher, C Thalamas, E Berard, C Lamy, Y Bejot, ...
The Lancet Neurology 10 (2), 123-130, 2011
8392011
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study
C Brefel‐Courbon, P Payoux, C Thalamas, F Ory, I Quelven, F Chollet, ...
Movement disorders: official journal of the Movement Disorder Society 20 (12 …, 2005
3392005
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
Y Cadroy, JP Bossavy, C Thalamas, L Sagnard, K Sakariassen, B Boneu
Circulation 101 (24), 2823-2828, 2000
3162000
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease
F Courbon, C Brefel‐Courbon, C Thalamas, MJ Alibelli, I Berry, ...
Movement disorders: official journal of the Movement Disorder Society 18 (8 …, 2003
2022003
A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36
L Naiglin, CH Gazagne, F Dallongeville, C Thalamas, A Idder, O Rascol, ...
Journal of medical genetics 39 (2), 118-124, 2002
2012002
Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study
A Gerdelat-Mas, M Simonetta-Moreau, C Thalamas, F Ory-Magne, ...
Journal of Neurology, Neurosurgery & Psychiatry 78 (10), 1140-1142, 2007
1982007
Atrial natriuretic peptide contributes to the physiological control of lipid mobilization in humans
C Moro, F Crampes, C Sengenes, ID Glisezinski, J Galitzky, C Thalamas, ...
The FASEB journal 18 (7), 908-910, 2004
1982004
In vivo regulation of human skeletal muscle gene expression by thyroid hormone
K Clément, N Viguerie, M Diehn, A Alizadeh, P Barbe, C Thalamas, ...
Genome research 12 (2), 281-291, 2002
1842002
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.
L Rostaing, E Chatelut, JL Payen, J Izopet, C Thalamas, H Ton-That, ...
Journal of the American Society of Nephrology 9 (12), 2344-2348, 1998
1841998
Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine
A Besse-Patin, E Montastier, C Vinel, I Castan-Laurell, K Louche, C Dray, ...
International journal of obesity 38 (5), 707-713, 2014
1692014
A randomized paired eye comparison of two techniques for treating moderately high myopia: LASIK and artisan phakic lens
FJ Malecaze, H Hulin, P Bierer, P Fournié, H Grandjean, C Thalamas, ...
Ophthalmology 109 (9), 1622-1630, 2002
1652002
Idazoxan, an alpha‐2 antagonist, and L‐DOPA‐induced dyskinesias in patients with Parkinson's disease
O Rascol, I Arnulf, H Peyro‐Saint Paul, C Brefel‐Courbon, M Vidailhet, ...
Movement disorders: official journal of the Movement Disorder Society 16 (4 …, 2001
1592001
Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass
A Girousse, G Tavernier, C Valle, C Moro, N Mejhert, AL Dinel, ...
PLoS Biol 11 (2), e1001485, 2013
1552013
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease
O Rascol, JG Nutt, O Blin, CG Goetz, JM Trugman, C Soubrouillard, ...
Archives of neurology 58 (2), 249-254, 2001
1472001
Exercise-induced immunodepression–plasma glutamine is not the link
N Hiscock, BK Pedersen
Journal of Applied Physiology 93 (3), 813-822, 2002
1432002
Natriuretic peptides enhance the oxidative capacity of human skeletal muscle
S Engeli, AL Birkenfeld, PM Badin, V Bourlier, K Louche, N Viguerie, ...
The Journal of clinical investigation 122 (12), 4675-4679, 2012
1352012
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial
F Ory-Magne, JC Corvol, JP Azulay, AM Bonnet, C Brefel-Courbon, ...
Neurology 82 (4), 300-307, 2014
1192014
The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men
J Galitzky, C Sengenès, C Thalamas, MA Marques, JM Senard, ...
Journal of lipid research 42 (4), 536-544, 2001
1162001
ABT‐431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease
O Rascol, O Blin, C Thalamas, S Descombes, C Soubrouillard, P Azulay, ...
Annals of Neurology: Official Journal of the American Neurological …, 1999
1151999
Triiodothyronine‐mediated upregulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes
P Barbe, D Larrouy, C Boulanger, E Chevillotte, N Viguerie, C Thalamas, ...
The FASEB Journal 15 (1), 13-15, 2001
1112001
The system can't perform the operation now. Try again later.
Articles 1–20